Page 116 - GPD-3-3

Gene & Protein in Disease Exploring serum inflammatory biomarkers in GBM

antigen-G is frequently expressed in glioblastoma and may doi: 10.1002/jcu.23402
be induced in vitro by combined 5-aza-2’-deoxycytidine and 60. Dobra G, Gyukity-Sebestyén E, Bukva M, et al. MMP-9 as
interferon-γ treatments: results from a multicentric study. prognostic marker for brain tumours: A comparative study
Am J Pathol. 2013;182(2):540-552. on serum-derived small extracellular vesicles. Cancers
doi: 10.1016/j.ajpath.2012.10.021 (Basel). 2023;15(3):
51. Gohar MK, Ammar MG, Alnagar AA, Abd-ElAziz HA. doi: 10.3390/cancers15030712
Serum IgE and allergy related genotypes of IL-4R α and 61. Quesnel A, Coles N, Polvikoski TM, et al. The diagnostic
IL-13 genes: Association with glioma susceptibility and and prognostic potential of the EGFR/MUC4/MMP9 axis in
glioblastoma prognosis. Egypt J Immunol. 2018;25(1): glioma patients. Sci Rep. 2022;12(1):19868.
19-33.
doi: 10.1038/s41598-022-24099-4
52. Wesley UV, Sutton I, Clark PA, et al. Enhanced expression
of pentraxin-3 in glioblastoma cells correlates with 62. Zhang D, Qiu B, Wang Y, Guan Y, Zhang L, Wu A.
increased invasion and IL8-VEGF signaling axis. Brain Res. Temozolomide increases MHC-I expression via NF-κB
2022;1776:147752. signaling in glioma stem cells. Cell Biol Int. 2017;41(6):
680-690.
doi: 10.1016/j.brainres.2021.147752
doi: 10.1002/cbin.10773
53. Brown CE, Rodriguez A, Palmer J, et al. Off-the-shelf,
steroid-resistant, IL13Rα2-specific CAR T cells for 63. Qiu ZK, Shen D, Chen YS, et al. Enhanced MGMT expression
treatment of glioblastoma. Neuro Oncol. 2022;24(8): contributes to temozolomide resistance in glioma stem-like
1318-1330. cells. Chin J Cancer. 2014;33(2):115-122.
doi: 10.5732/cjc.012.10236
doi: 10.1093/neuonc/noac024
64. Teng J, da Hora CC, Kantar RS, et al. Dissecting inherent
54. Chiorean R, Berindan-Neagoe I, Braicu C, et al. Quantitative
expression of serum biomarkers involved in angiogenesis intratumor heterogeneity in patient-derived glioblastoma
and inflammation, in patients with glioblastoma multiforme: culture models. Neuro Oncol. 2017;19(6):820-832.
Correlations with clinical data. Cancer Biomark. 2014;14(2- doi: 10.1093/neuonc/now253
3):185-194. 65. Urbanavičiūtė R, Skauminas K, Skiriutė D. The evaluation of
doi: 10.3233/cbm-130310 AREG, MMP-2, CHI3L1, GFAP, and OPN serum combined
value in astrocytic glioma patients’ diagnosis and prognosis.
55. Albulescu R, Codrici E, Popescu ID, et al. Cytokine Brain Sci. 2020;10(11):872.
patterns in brain tumour progression. Mediators Inflamm.
2013;2013:979748. doi: 10.3390/brainsci10110872
doi: 10.1155/2013/979748 66. Sreekanthreddy P, Srinivasan H, Kumar DM, et al.
Identification of potential serum biomarkers of glioblastoma:
56. Xu J, Fang J, Cheng Z, et al. Overexpression of the Serum osteopontin levels correlate with poor prognosis.
Kininogen-1 inhibits proliferation and induces apoptosis of Cancer Epidemiol Biomarkers Prev. 2010;19(6):1409-1422.
glioma cells. J Exp Clin Cancer Res. 2018;37(1):180.
doi: 10.1158/1055-9965.Epi-09-1077
doi: 10.1186/s13046-018-0833-0
67. El-Benhawy SA, Sakr OA, Fahmy EI, et al. Assessment of
57. Panitz V, Končarević S, Sadik A, et al. Tryptophan serum hypoxia biomarkers pre- and post-radiotherapy in
metabolism is inversely regulated in the tumor and blood patients with brain tumors. J Mol Neurosci. 2022;72(11):
of patients with glioblastoma. Theranostics. 2021;11(19): 2303-2312.
9217-9233.
doi: 10.1007/s12031-022-02065-z
doi: 10.7150/thno.60679
68. Masood AB, Batool S, Bhatti SN, et al. Plasma PD-L1 as
58. Muller Bark J, Karpe AV, Doecke JD, et al. A pilot study: a biomarker in the clinical management of glioblastoma
Metabolic profiling of plasma and saliva samples from multiforme-a retrospective cohort study. Front Immunol.
newly diagnosed glioblastoma patients. Cancer Med. 2023;14:1202098.
2023;12(10):11427-11437.
doi: 10.3389/fimmu.2023.1202098
doi: 10.1002/cam4.5857
69. De Martino M, Daviaud C, Minns HE, et al. Radiation
59. Liu W, Li Z. Diagnostic performance of perfusion-weighted therapy promotes unsaturated fatty acids to maintain
imaging combined with serum MMP-2 and -9 levels survival of glioblastoma. Cancer Lett. 2023;570:216329.
in tumor recurrence after postoperative concomitant
chemoradiotherapy of glioblastoma. J Clin Ultrasound. doi: 10.1016/j.canlet.2023.216329
2023;51(3):563-570. 70. Brüning A, Runnebaum IB. CAR is a cell-cell adhesion

Volume 3 Issue 3 (2024) 16 doi: 10.36922/gpd.3580